Last reviewed · How we verify
NCT05007626
Near Horizontal Heterophoria in Chinese Children
trial testing axial length and refractive error in Myopia, Progressive in 15,081 participants. Completed in 31 December 2017.
30 December 2017
Quick facts
| Lead sponsor | Tianjin Eye Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 15,081 |
| Start date | 29 January 2017 |
| Primary completion | 30 December 2017 |
| Estimated completion | 31 December 2017 |
| Sites | 1 location across China |
Drugs / interventions tested
- axial length and refractive error
Conditions studied
- Myopia, Progressive — all drugs for Myopia, Progressive →
Sponsor
Tianjin Eye Hospital
Who can join
Adults 6 to 13, any sex, with Myopia, Progressive. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to assess the association of refraction and axial length with near-horizontal heterophoria in a large population-based study of school-aged Chinese children. The study makes a significant contribution to better know the etiology of myopia progression and ocular axial length development. Further, this study will be of interest to the readership of your journal because its noteworthy finding and which could contribute to guide recommendations for targeted interventions to slow myopia progression.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05007626
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myopia, Progressive
Currently open trials in the same condition.
- NCT06927388 — Myopia Progression With Freeform Myopia Control Spectacles · NA · active not recruiting
- NCT07055815 — Impact of Digital Screen Time in Progression of Myopia in Children · active not recruiting
- NCT06389110 — Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elo · Phase 3 · recruiting
- NCT06647160 — Safety and Efficacy of Blue Star MAX-5 Lenses in Myopia Control · NA · active not recruiting
- NCT06520124 — Stellest Lens Wear in Adult Progressing Myopes · NA · active not recruiting
Other Tianjin Eye Hospital trials
Trials by the same sponsor.
- NCT07518316 — Factors Influencing Subjective Visual Quality in Human Eyes · NA · not yet recruiting
- NCT06993077 — Impact of Ultraviolet Radiation and Environmental Factors on Human Ocular Biomechanics · active not recruiting
- NCT06694051 — Application of Phototherapeutic Keratectomy Mode to Mark the Axis of Astigmatism · NA · recruiting
- NCT07244276 — Comparison of Compressed Continuous Suture and Conventional Suture in Pterygium Surgery · NA · recruiting
- NCT07171710 — Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögr · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05007626 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin Eye Hospital
- Last refreshed: 16 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05007626.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing